Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A4SMP5

Entry ID Method Resolution Chain Position Source
AF-A4SMP5-F1 Predicted AlphaFoldDB

No variants for A4SMP5

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for A4SMP5

No associated diseases with A4SMP5

3 regional properties for A4SMP5

Type Name Position InterPro Accession
domain Histidine biosynthesis HisG, C-terminal 201 - 297 IPR013115
domain ATP phosphoribosyltransferase, catalytic domain 6 - 218 IPR013820
conserved_site ATP phosphoribosyltransferase, conserved site 155 - 176 IPR018198

Functions

Description
EC Number 2.4.2.17 Pentosyltransferases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP phosphoribosyltransferase activity Catalysis of the reaction: 1-(5-phospho-D-ribosyl)-ATP + diphosphate = ATP + 5-phospho-alpha-D-ribose 1-diphosphate.
magnesium ion binding Binding to a magnesium (Mg) ion.

1 GO annotations of biological process

Name Definition
histidine biosynthetic process The chemical reactions and pathways resulting in the formation of histidine, 2-amino-3-(1H-imidazol-4-yl)propanoic acid.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
METQRLRIAM QKSGRLSQDS QALFKSCGLK INLREQRLIA HVENMPIDIL RVRDDDIPGL
70 80 90 100 110 120
VMEGVVDLGI IGENVLEEAQ LIRASQGLPA QVKTLKQLDF GGCRLSLAVP DDVAYTGPES
130 140 150 160 170 180
LAGKRIATSY PGLLKRFFDE KGLNFKSVML GGSVEVAPRA GLADAICDLV STGATLEANG
190 200 210 220 230 240
LKEVEVIYRS KAVLVQAPNP LNEAKQKLID KLLPRIQGMQ QARESKYIML HAPKDKLDAI
250 260 270 280 290
TDLLPGAERP TIMQLAGDTN QVALHVVSSE TLFWETMEQL KALGASSILV LPIEKMME